![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Buy article online]](/logos/buy.gif)
![[Contents scheme]](lh2073contents.gif)
Acta Cryst. (2006). E62, o2358-o2360 [ doi:10.1107/S1600536806017338 ]
Abstract: The title compound [systematic name: (3S,6S)-3,6-bis(S-sec-butyl)-2,5-piperazine-2,5-dione], C12H22N2O2, was crystallized from a solution of the corresponding linear peptide L-isoleucyl-L-isoleucine. In the crystal structure, molecules form traditional N-H
O hydrogen-bonded tapes along the a axis [a = 6.242 (9) Å].
Online 17 May 2006
Copyright © International Union of Crystallography
IUCr Webmaster